Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the…
The Breakthrough Therapy designation is based on the significant improvement in efficacy metrics demonstrated by the sublingual tablets in a previous clinical study. The data from a multicenter, randomized, double-blind, parallel, placebo-controlled Phase III clinical study in China for the treatment of AIS demonstrated that Sanbexin sublingual tablets significantly improved neurological recovery and independent living ability in patients with AIS compared to placebo, meeting the expected…
PR Newswire
05/09/2024
Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on…
Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on September 12, and to Host KOL Event on September 30, 2024Halle (Saale) / Munich, Germany, September 5 , 2024- Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon ), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of pathologically altered proteins, today announced that it will host two events in...
Nasdaq GlobeNewswire
05/09/2024
LG TO INTRODUCE EXCITING VISION FOR FUTURE LIVING WITH "LG AI HOME" INNOVATIONS…
Central to LG's Affectionate Intelligence Home is LG ThinQ ON, an advanced AI home hub designed to deliver comfort and convenience tailored to individual preferences. ThinQ ON seamlessly integrates with LG's latest AI appliances, forming the core of the LG AI Home Solution. This system is driven by Affectionate Intelligence, LG's empathetic and caring AI technology. As the AI Home Solution learns more about users' routines, preferences and behaviors over time, it creates a personalized spatial…
PR Newswire
05/09/2024
Global Heparin Market to Reach ~USD 15 Billion by 2030 | DelveInsight
Key Takeaways from the Heparin Market Report Key Takeaways from the Heparin Market Report To read more about the latest highlights related to the heparin market, get a snapshot of the key highlights entailed in the Global Heparin Market Report Heparin Overview Heparin is a widely used anticoagulant medication that helps prevent and treat blood clots. It works by enhancing the activity of antithrombin III, a protein in the blood that inhibits blood clotting factors such as...
PR Newswire
04/09/2024
Chronic Venous Insufficiency Market to Show Immense Growth at a CAGR of 9.5% by…
Key Takeaways from the Chronic Venous Insufficiency Market Report Key Takeaways from the Chronic Venous Insufficiency Market Report Discover which therapies are expected to grab the major chronic venous insufficiency market share @ Chronic Venous Insufficiency Market Report Chronic Venous Insufficiency Overview Chronic venous disease (CVD) is a common condition that affects the venous system, particularly the veins in the lower limbs. It includes a range of venous disorders,...
PR Newswire
04/09/2024
Monthly information on share capital and company voting rights
(Article 223-16 of General Regulation of the French financial markets authority) Listing market: Euronext Growth ISIN code: FR0010425595DateTotal number of shares in the capitalTotal number of voting rights 08/31/2024100,093,63588,029,440 For further information on Cellectis, please contact: Media contact: Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33,media@cellectis.com Patricia Sosa Navarro, Chief of Staff to the...
Nasdaq GlobeNewswire
04/09/2024
DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global…
DBV Technologies to Participate in the H.C. Wainwright 26 thAnnual Global Investment Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Daniel Tassé, Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 26 thAnnual Global Investment Conference on Monday, September 9, 2024, at 3:00 pm ET, in New York City.A live webcast of the presentation can...
Nasdaq GlobeNewswire
04/09/2024
NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further…
Dr. Margaret A. Liu, global expert in vaccines, gene therapy, and cancer immunotherapy; chief executive officer of PAX Therapeutics and member of several boardsMs. Anat Naschitz, proven life science investor and entrepreneur; co-founder of OrbiMed IsraelPARIS and CAMBRIDGE, Mass., Sept.04, 2024(GLOBE NEWSWIRE) --NANOBIOTIX(Euronext: NANO –– NASDAQ: NBTX – the '' Company ''), a late-clinical stage biotechnology company pioneering nanoparticle-based therapeutic approaches to...
Nasdaq GlobeNewswire
04/09/2024
Ipsen - August 2024 - Monthly information relative to the total number of voting…
Monthly information relative to the total number of voting rightsand shares composing the share capital(in accordance with Article L.233-8 II of the French Commercial Code andArticle 223-16 of the General Regulation of theAutorité des Marchés Financiers ) Market: Euronext ParisISIN Code: FR 0010259150 LEI: 549300M6SGDPB4Z94P11 DateTotal number of shares composing the share capitalTotal number of voting rights(1) 31 August 202483,814,526Gross total*...
Nasdaq GlobeNewswire
04/09/2024
VALNEVA - Declaration of shares and voting rights: August 31, 2024
VALNEVADeclaration of shares and voting rightsAugust 31, 2024__________________________________________________________________________________________Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France) Regulated market of Euronext Paris - Compartment B Declaration date: September 4, 2024 Number of sharescomposing the share capital of ValnevaTotal number of voting rights including suspended voting rights* Description of the...
Nasdaq GlobeNewswire
04/09/2024
Autoinjectors Market to Hit USD 3.02 Billion by 2030: Growth Drivers, Key…
Browse in-depth TOC on "Autoinjectors Market" Browse in-depth TOC on "Autoinjectors Market" 527 - Tables75 - Figures382 - Pages Factors Driving Market Growth Key drivers of the autoinjectors market include the increased adoption of these devices due to their ease of use, along with a rise in approvals for biosimilars and biologics. Technological advancements such as Bluetooth connectivity, dose monitoring, adherence tracking, and data sharing with healthcare providers...
PR Newswire
04/09/2024
Medical Foam Market Surges to USD 47.2 Billion by 2030, Propelled by 6.5% CAGR -…
Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=433158 Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=433158 Browse in-depth TOC on Medical Foam Market 202 - Pages 126 – Tables 37 – Figures Scope of The Report Global Medical Foam Market Overview Market Drivers Fueling Growth in the Medical Foam Market Rising Demand for Advanced Wound Care Products:The growing prevalence of chronic...
PR Newswire
04/09/2024
Refurbished Medical Imaging Equipment Market is expected to generate a revenue…
Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=40275 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=40275 Browse in-depth TOCon" Global Refurbished Medical Imaging Equipment Market Size " 202 - Pages 126 – Tables 37 – Figures Report Scope Global Refurbished Medical Imaging Equipment Market Overview Cost-Effectiveness and Affordability : One of the main factors contributing to the...
PR Newswire
04/09/2024
Charles River and Insightec Announce Strategic Collaboration to Advance…
"Our collaboration with Insightec represents a significant step forward in advancing neuroscience research," said ProfessorJulie Frearson, PhD, Senior Vice President and Chief Scientific Officer at Charles River. "As we look toward the future of drug discovery, we recognize that technology will be a cornerstone of innovation. The integration of focused ultrasound technology into our preclinical services will enhance the precision and effectiveness of therapeutic delivery...
PR Newswire
04/09/2024
Pharma Targeting celebrates a year of growth and milestones amid industry…
Founded by Anil Kumar, an immunologist turned entrepreneur, Pharma Targeting - part of The Targeting Group - partners with global clients to deliver comprehensive business development strategies using a revolutionary 3 Step Model, which identifies and secures high-value, first-to-market opportunities. Their approach is designed to ensure clients get in front of 70+ decision-makers annually, whilst saving both time and money. Founded by Anil Kumar, an immunologist turned entrepreneur…
PR Newswire
04/09/2024
Signant Health expands availability of its eClinical solutions by joining IQVIA…
One such technology solution that will appear on the One Home for Sites platform is Signant SmartSignals® Unified Platform, itself a fully integrated solution consisting of eCOA, EDC, RTSM, eConsent, and telemedicine. One such technology solution that will appear on the One Home for Sites platform is Signant SmartSignals® Unified Platform, itself a fully integrated solution consisting of eCOA, EDC, RTSM, eConsent, and telemedicine. "We are very pleased to have our Unified Platform now...
PR Newswire
04/09/2024
Phesi Receives Frost & Sullivan's Global Enabling Technology Leadership Award…
Frost & Sullivan presents this annual award to a company that has developed pioneering technology that not only enhances current products but enables the development of new products and applications. Frost & Sullivan presents this annual award to a company that has developed pioneering technology that not only enhances current products but enables the development of new products and applications. Aarti Siddhesh Chitale, healthcare senior industry analyst at Frost & Sullivan,...
PR Newswire
04/09/2024
Real World Data Supports Lenire Tinnitus Treatment Effectiveness Shown in…
The paper is available at: https://doi.org/10.1101/2024.08.22.24312175 The paper is available at:https://doi.org/10.1101/2024.08.22.24312175 Tinnitus, which is commonly known as'ringing in the ears', is a complex neurological condition that causes a perception of sound when there is no external source. It is estimated that at least 25 million Americans are currently living with tinnitus 3. Tinnitus is also the most prevalent service-connected disability compensated for by The United...
PR Newswire
04/09/2024
Biogen Announces Positive Topline Results from Study of Higher Dose Regimen of…
Positive study demonstrates the potential for investigational higher dose nusinersen regimen to advance the treatment of SMA; Biogen plans to submit for regulatory approval of this investigational dose regimen Higher dose nusinersen regimen showed statistically significant improvement compared to a prespecified matched sham control groupAmong key measures of clinical efficacy, higher dose regimen showed positive trends compared to the approved dosing regimenCAMBRIDGE, Mass., Sept...
Nasdaq GlobeNewswire
04/09/2024
iSTAR Medical continues to strengthen US presence with appointment of Chief…
For immediate release iSTAR Medical continues to strengthen US presence with appointment of Chief Medical Officer and Vice President of Clinical AffairsWAVRE, Belgium — 4 September 2024 :iSTAR Medical, a medtech company delivering breakthrough eye care solutions to patients, today announces the strengthening of its leadership team with the appointment of Richard (Rick) Beckman, M.D., as Chief Medical Officer and member of the Board, and Kristine (Kris) Curtiss as Vice President of...
Nasdaq GlobeNewswire
04/09/2024
Olon Continues its Growth Path and Announces a New Acquisition
Olon, the leading chemical-pharmaceutical group in the production and development of active pharmaceutical ingredients (APIs) and part of the holding company P&R, continues its growth path and announces a new venture: it will acquire HuvePharma Italia Srl and its site in Garessio, (Cuneo, Italy) with a significant increase in its total production capacity MILAN, Sept.04, 2024(GLOBE NEWSWIRE) -- The acquisition plan involves a complete operational integration of Huvepharma Italia...
Nasdaq GlobeNewswire
04/09/2024
Shampoo Market to Reach $58.3 Billion, Globally, by 2034 at 5.1% CAGR: Allied…
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A06353 Download Sample Pages of Research Overview:https://www.alliedmarketresearch.com/request-sample/A06353 Prime determinants of growth Increase in consumer awareness of personal hygiene and hair health led to higher demand for specialized shampoos that address various concerns, such as dandruff, hair loss, and damage repair. Innovations in product formulations, including natural...
PR Newswire
04/09/2024
ZINZINO AB (PUBL): PRELIMINARY SALES REPORT AUGUST 2024
Accumulated revenue for January – August 2024 increased by 21 % to SEK 1309.4 (1080.3) million. Accumulated revenue for January –August 2024increased by 21 % toSEK 1309.4(1080.3) million. Revenues were distributed as follows: Countries in regions: -The Nordics:Denmark, Faroe Island,Finland,Iceland,Norway,Sweden- Central Europe :Austria,Germany,Switzerland- East Europe :Czech Republic,Slovakia,Hungary,Poland,Romania-South &West...
PR Newswire
04/09/2024
21st.BIO obtains self-affirmed GRAS status for its precision fermented…
Beta-lactoglobulin is a potent and highly nutritious dairy protein Beta-lactoglobulin is a potent and highly nutritious dairy protein The predominant protein in bovine whey, beta-lactoglobulin (BLG) has attracted considerable food-producer interest for its high-quality nutrition and advantageous properties in food product formulation. Its nutritional profile is impressive, boasting a larger amount of essential and branched-chain amino acids than whey. For example: 21st.BIO...
PR Newswire
04/09/2024
Altri Comunicati
